Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection
Thermo Fisher Scientific (United States)
Abstract
CRISPR-Cas9 systems provide a platform for high efficiency genome editing that are enabling innovative applications of mammalian cell engineering. However, the delivery of Cas9 and synthesis of guide RNA (gRNA) remain as steps that can limit overall efficiency and ease of use. Here we describe methods for rapid synthesis of gRNA and for delivery of Cas9 protein/gRNA ribonucleoprotein complexes (Cas9 RNPs) into a variety of mammalian cells through liposome-mediated transfection or electroporation. Using these methods, we report nuclease-mediated indel rates of up to 94% in Jurkat T cells and 87% in induced pluripotent stem cells (iPSC) for a single target. When we used this approach for multigene targeting in…
Citation impact
- FWCI
- 29.81
- Percentile
- 100%
- References
- 22
Authors
12Topics & keywords
- Cas9
- CRISPR
- Transfection
- Genome engineering
- Guide RNA
- Genome editing
- Electroporation
- Jurkat cells
- Industry, innovation and infrastructure